NARHEX LIFE SCIENCES LIMITED (NLS)

Research and commercial development of drugs for the treatment of HIV/AIDS.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
NLS	0.006	0%	0.005	0.006	0.000	0.000	0.000	0

NARHEX LIFE SCIENCES LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	NLS
Securities	ASX Code, Security Description ------------------------------ NLS, Ordinary Fully Paid
Official Listing Date	12 January, 2005
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.narhex.com.au
Registered Office Address	Level 24, 44 St George's Terrace, PERTH, WA, AUSTRALIA, 6000
Head Office Telephone	+61 8 6211 5099
Head Office Fax	+61 8 9218 8875
Share Registry	LINK MARKET SERVICES LIMITED GROUND FLOOR, 178 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone	1300 554 474

Directors / Senior Management
Mr Peter Christie (Chairman) Mr Cyril D'Silva (Director) Mr Simon Lill (Director) Mr David Mandel (Director) Mr Adam Sierakowski (Alternate Director)

Company Secretary	Ms Nicki Farley
Principal Activities	Research and commercial development of drugs for the treatment of HIV/AIDS.

NARHEX LIFE SCIENCES LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
22/05/2013		Initial Director's Interest Notice	4	PDF
16/05/2013		Director Appointments	1	PDF
01/05/2013		Company Update	3	PDF
30/04/2013		Appendix 4C - quarterly	5	PDF
28/02/2013		Half Yearly Report and Accounts - 31 December 2012	22	PDF
28/02/2013		Liberian Gold and Diamond Project - Due Diligence Update	4	PDF
27/02/2013		Initial Director's Interest Notice	2	PDF
22/02/2013		Director Appointment	1	PDF
31/01/2013		Appendix 4C - quarterly	5	PDF
31/01/2013		Update on Coal Tenements - Waiver of Options	1	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
22 May 2013	0.006	20%	0.006	0.006	100,000
21 May 2013	0.005	25%	0.005	0.005	1,000,000
15 May 2013	0.004	-20%	0.005	0.004	1,488,149
09 May 2013	0.005	25%	0.005	0.005	188,000
08 May 2013	0.004	-20%	0.004	0.003	15,000

* Volume of shares shown represents only those shares traded on ASX.

NARHEX LIFE SCIENCES LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security NLS. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security NLS

Warrants & Structured Products

No warrants & Structured Products are available over the security NLS

ASX CFDs

No Contracts For Differences are available over the security NLS

MyASX: Login | Sign up